PUBLISHER: The Insight Partners | PRODUCT CODE: 2042676
PUBLISHER: The Insight Partners | PRODUCT CODE: 2042676
According to our new research study on "Knee Reconstruction Market Forecast to 2034 -Global Analysis - by Procedure, Technique, End User, and Geography," the market is anticipated to grow from US$ 14.98 billion in 2025 to US$ 25.09 billion by 2034, with a CAGR of 6.0% during 2026-2034. The knee reconstruction market growth is attributed to the increasing aging population and osteoarthritis prevalence, and the surge in obesity rates, exacerbating knee joint stress.
Knee reconstruction is a surgical procedure done to repair the structure, stability, and function of an injured knee joint due to either an accident, degeneration, or illness. The process involves repairing and/or replacing parts of the knee with grafting, implanting, or using an artificial device. The main objectives are for pain relief, improved mobility, and to allow patients to return to their normal daily or physical activities. Among the major market trends are widespread integration of artificial intelligence and machine learning for implant sizing and patient-specific outcome prediction, and transition to regenerative medicine and tissue-engineering approaches for biological cartilage restoration.
The knee reconstruction market in North America is segmented into the US, Canada, and Mexico. The North America knee reconstruction market growth is supported through national registries and high osteoarthritis prevalence driven by aging and obesity. The US holds the largest market share, followed by Canada.
The US is leading in total knee reconstruction volumes (through national inpatient sampling and the world's largest total joint treatment registry) with 818,000 total knee arthroplasties recorded in 2019. The increase in primary total knee arthroplasties (TKAs) correlates with substantial increases in primary and revision arthroplasties performed, based on the 2024 AJRR Annual Report. The AJRR analyzed 3.7 million validated TKAs and revisions from January 1, 2012 to December 31, 2023 at 1,447 facilities across all 50 states, and established that there has been continued high volume activity post pandemic. According to the Global Burden of Disease Study 2021, there were 25,007,735 cases of osteoarthritis in the United States, with an age-standardized prevalence of 8,228.1 per 100,000 and years lived with disability at the highest level of any high-income country. Together, the robust data supporting the continued success of the TKAs performed in outpatient settings combined with orthopedic navigation systems continue to secure the US number one market share for total knee replacements in the world.
The US Food and Drug Administration, World Bank Data, American Academy of Orthopaedic Surgeons, FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization), Asia Pacific Orthopaedic Association are among the primary and secondary sources referred to while preparing the knee reconstruction market report.